Regional variability in the prevalence of cerebral white matter lesions: An MRI study in 9 European countries (CASCADE)

Neuroepidemiology

Volumn 26, Issue 1, 2005, Pages 23-29

  Launer, L J ^a,b   Berger, K ^c   Breteler, M M B ^b   Dufouil, C ^d   Fuhrer, R ^e   Giampaoli, S ^f   Nilsson, L G ^g   Pajak, A ^h   De Ridder, M ^b   Van Dijk, E J ^b   Sans, S ⁱ   Schmidt, R ^j   Hofman, A ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e MCGILL UNIVERSITY   (Canada)

^f ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^g STOCKHOLM UNIVERSITY   (Sweden)

^h JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

ⁱ INSTITUT CATALÀ DE LA SALUT   (Spain)

^j UNIVERSITY OF GRAZ   (Austria)

more..

Author keywords

Cardiovascular; Epidemiology; Multicenter study; White matter lesion

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRIA; BRAIN DEGENERATION; BRAIN DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEMOGRAPHY; DISABILITY; EUROPE; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; GERMANY; HEALTH CARE PLANNING; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLAND; POPULATION; RISK FACTOR; SPAIN; SWEDEN; UNITED KINGDOM; WHITE MATTER; WHITE MATTER LESION;

AGED; AGING; BLOOD PRESSURE; BRAIN; BRAIN DISEASES; COHORT STUDIES; EDUCATION; EUROPE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 29144517404     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089233     Document Type: Article

References (31)

1. Scheltens P: Early diagnosis of dementia: neuroimaging. J Neurol 1999;246:16-20.
2. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LMP, Heijboer R, Hofman A, Jolles J, van Gijn J, Breteler MMB: Prevalence of cerebral white matter lesions in elderly people: a population-based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001;70:9-14.
3. de Groot JC, de Leeuw FE, Oudkerk M, van Gijn J, Hofman A, Jolies J, Breteler MMB: Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000;47:145-151.
4. Steffens DC, Helms MJ, Krishnan RR, Burke GL: Cerebrovascular disease and depression symptoms in the Cardiovascular Health Study. Stroke 1999;30:2159-2166.
5. Tell GS, Lefkowitz DS, Diehr P, Elster AD: Relationship between balance and abnormalities in cerebral magnetic resonance imaging in older adults. Arch Neurol 1998;55:73-79.
6. Pantoni L, Garcia JH: Pathogenesis of leukoaraiosis. Stroke 1997;28:652-659.
7. Keys A, Menotti A, Aravanis C, Blackburn H, Djordevic BS, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Kimura N, et al: The seven countries study: 2,289 deaths in 15 years. Prev Med 1984;13:141-154.
8. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, Mähönen M, Cepaitis Z, Kuulasmaa K, Keil U, for the WHO MONICA Project: Estimation of contribution of changes in coronary care to improving survival, event rates and coronary heart disease mortality across the WHO MONICA Project Populations. Lancet 1999;353:1547-1557.
9. Pantoni L, Garcia JH: The significance of cerebral white matter abnormalities 100 years after Biswanger's report. Stroke 1995;26:1293-1301.
10. Scheltens P, Erkinjuntti T, Leys D, Wahlund LO, Inzitari D, del Ser T, Pasquier F, Barkhof F, Mantyla R, Bowler J, Wallin A, Ghika J, Fazekas F, Pantoni L: White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol 1998;39:80-89.
11. Sans S, Kesteloot H, Kromhout, on behalf of the Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe: The burden of cardiovascular disease in Europe. Eur Heart J 1997;18:1231-1248.
12. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A: Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 1999;52:78-84.
13. Launer LJ, Oudkerk M, Nilsson LG, Alperovitch A, Berger K, Breteler MM, Fuhrer R, Giampaoli S, Nissinen A, Pajak A, Sans S, Schmidt R, Hofman A: CASCADE: A European collaborative study on vascular determinants of brain lesions. Study design and objectives. Neuroepidemiology 2000;19:113-120.
14. Dufouil C, de Kersaint-Gilly A, Besançon V, Kevy C, Auffray E, Brunnereau L, Alpérovitch A, Tzourio C: Longitudinal study of blood pressure and white matter hyperintensities. The EVA MRI cohort. Neurology 2001;56:921-926.
15. Hense HW, Stieber J, Filipiak B, Keil U: 5-year changes in population blood pressure and hypertension prevalence. Results from the Monica Augsburg Germany 1984/85 and 1989/90. Ann Epidemiol 1993;3:410-416.
16. Giampaoli, S, Poce A, Sciarra F, Lo Noce Dima C, Minoprio A, Santaquilani P, Caiola De P, Sanctis Volpe A, Menditto A, Menotti A, Urbinati GC: Change in cardiovascular risk factors during a 10-year community intervention program. Acta Cardiologica 1997;5:411-422.
17. Pajak A: Job and blood lipids. Findings of POL-MONICA Krakow Study. Acta Cardiolog 1994;4:343-345.
18. Sans S, Paluzie G Balañá L, Puig T, Balaguer-Vintró I: Trends in prevalence, awareness and treatment of arterial hypertension between 1986 and 1996: MONICA-Catalonia study (in Spanish, abstract in English). Med Clin (Barc) 2001;117:246-253.
19. Erratum in Med Clin (Barc) 2001;117:731.
20. Marmot MG, Davey Smith G, Stansfeld SA, Patel C, North F, Head J, White I, Brunner EJ, Feeney A: Health inequalities among British Civil Servants: the Whitehall II study. Lancet 1991;337:1387-1393.
21. Schmidt R, Lechner H, Fazekas F, Niederkorn K, Reinhart B, Grieshofer P, Horner S, Offenbacher H, Koch M, Eber B, Schumacher M, Kapeller P, Freidl W, Dusek T: Assessment of cerebrovascular risk profiles in healthy persons: definition of research goals and the Austrian Stroke Prevention Study. Neuroepidemiology 1994;13:308-313.
22. Nilsson LG, Bachman L, Erngrund K, Nyberg L, Adolfsson R, Bucht G, Karlsson S, Widing M, Winblad B: The Betula prospective cohort study: memory, health, and aging. Aging Neuropsych Cogn 1997;4:1-32.
23. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
24. Radloff LS: The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977:3;385-401.
25. Schmidt R, Launer LJ, Nilsson LG, Pajak A, Sans S, Berger K, Breteler MM, De Ridder M, Dufouil C, Fuhrer R, Giampaoli S, Hofman A: Magnetic resonance imaging of the brain in diabetes: The Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 2004;53:687-692.
26. van Dijk EJ, Breteler MM, Schmidt R, Berger K, Nilsson LG, Oudkerk M, Pajak A, Sans S, Ridder MD, Dufouil C, Fuhrer R, Giampaoli S, Launer LJ, Hofman A: The association between blood pressure, hypertension, and cerebral white matter lesions. The Cardiovascular Determinants of Dementia Study. Hypertension 2004;44:625-630.
27. SAS Institute Inc: SAS/STAT User's Guide. Version 8, 1999. Cary, N.C., USA.
28. Reed DM: The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol 1990;131:579-588.
29. Truelsen T, Mahonen M, Tolonen H, Asplund K, Bonita R, Vanuzzo D: WHO MONICA Project. Trends in stroke and coronary heart disease in the WHO MONICA Project. Stroke 2003;34:1346-1352.
30. Guralnik JM, Fried LP, Salive ME: Disability as a public health outcome in the aging population. Annu Rev Public Health 1996;17:25-46.
31. Truelsen T, Mahonen M, Tolonen H, Asplund K, Bonita R, Vanuzzo D, WHO MONICA Project. Trends in stroke and coronary heart disease in the WHO MONICA Project. Stroke 2003;34:1346-1352.